SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-330090
Filing Date
2021-11-15
Accepted
2021-11-15 17:07:14
Documents
14
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d242954d10ka.htm   iXBRL 10-K/A 49229
2 EX-31.1 d242954dex311.htm EX-31.1 9962
3 EX-31.2 d242954dex312.htm EX-31.2 9941
  Complete submission text file 0001193125-21-330090.txt   255982

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cort-20201231.xsd EX-101.SCH 2515
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20201231_lab.xml EX-101.LAB 26935
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20201231_pre.xml EX-101.PRE 16607
7 EXTRACTED XBRL INSTANCE DOCUMENT d242954d10ka_htm.xml XML 7242
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-50679 | Film No.: 211412224
SIC: 2834 Pharmaceutical Preparations